TY - JOUR T1 - Rare pulmonary disease and orphan drugs: a path to the future JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW DO - 10.1183/16000617.0115-2019 VL - 28 IS - 153 SP - 190115 AU - Sergio Harari AU - Yochai Adir AU - Marc Humbert Y1 - 2019/09/30 UR - http://err.ersjournals.com/content/28/153/190115.abstract N2 - In this issue of the European Respiratory Review (ERR), we are delighted to publish a series of articles on rare pulmonary diseases discussing hot topics presented at the 8th International Meeting on Pulmonary Rare Diseases and Orphan Drugs, which took place in Milan, Italy in March 2019. The meeting was endorsed by the European Respiratory Society and the European Reference Network – LUNG; a network of healthcare providers dedicated to the care and investigation of patients suffering from rare respiratory diseases approved by the European Commission's Board of Member States in December 2016 (https://ec.europa.eu/health/ern/networks_en) [1].The interest in rare diseases is growing. The progress in this field has been made possible by a coordinated action between respiratory researchers, health authorities and patients associations. http://bit.ly/2kIurPH ER -